Short answer
Medline Inc (MDLN) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 7.01 (Regulation FD Disclosure). Voluntary exit from all Medline Brand beds and related products, eliminating a Front Line Care product line.
Medline Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Voluntary exit from all Medline Brand beds and related products, eliminating a Front Line Care product line
- Affected products generated approximately $60 million in sales over the twelve months ended June 27, 2026
- Estimated field-action costs up to $220 million, including inventory impairment, disposal costs, and customer credits
- Costs expected in 2026 and 2027, excluded from Adjusted EBITDA
- No material fiscal 2026 impact expected, including no change to guidance as of August 5, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Medline Inc 8-K filings
Get the next MDLN 8-K as it lands
Follow MDLN for push alerts, or ask the research agent what this filing means.